Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population?
Identifieur interne : 000315 ( PubMed/Curation ); précédent : 000314; suivant : 000316Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population?
Auteurs : J L Olds [États-Unis] ; N. Kabbani [États-Unis]Source :
- The FEBS journal [ 1742-4658 ] ; 2020.
Abstract
The recent emergence of COVID-19 has resulted in a worldwide crisis, with large populations locked down and transportation links severed. While approximately 80% of infected individuals have minimal symptoms, around 15-20% need to be hospitalized, greatly stressing global health care systems. As of March 10, the death rate appears to be about 3.4%, although this number is highly stratified among different populations. Here, we focus on those individuals who have been exposed to nicotine prior to their exposure to the virus. We predict that these individuals are "primed" to be at higher risk because nicotine can directly impact the putative receptor for the virus (ACE2) and lead to deleterious signaling in lung epithelial cells.
DOI: 10.1111/febs.15303
PubMed: 32189428
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000315
Links to Exploration step
pubmed:32189428Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population?</title>
<author><name sortKey="Olds, J L" sort="Olds, J L" uniqKey="Olds J" first="J L" last="Olds">J L Olds</name>
<affiliation wicri:level="1"><nlm:affiliation>SCHAR School of Public Policy, George Mason University, Arlington, VA, 22201, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>SCHAR School of Public Policy, George Mason University, Arlington, VA, 22201</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kabbani, N" sort="Kabbani, N" uniqKey="Kabbani N" first="N" last="Kabbani">N. Kabbani</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Systems Biology, George Mason University, Fairfax, VA, 22030, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>School of Systems Biology, George Mason University, Fairfax, VA, 22030</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32189428</idno>
<idno type="pmid">32189428</idno>
<idno type="doi">10.1111/febs.15303</idno>
<idno type="wicri:Area/PubMed/Corpus">000315</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000315</idno>
<idno type="wicri:Area/PubMed/Curation">000315</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000315</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population?</title>
<author><name sortKey="Olds, J L" sort="Olds, J L" uniqKey="Olds J" first="J L" last="Olds">J L Olds</name>
<affiliation wicri:level="1"><nlm:affiliation>SCHAR School of Public Policy, George Mason University, Arlington, VA, 22201, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>SCHAR School of Public Policy, George Mason University, Arlington, VA, 22201</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kabbani, N" sort="Kabbani, N" uniqKey="Kabbani N" first="N" last="Kabbani">N. Kabbani</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Systems Biology, George Mason University, Fairfax, VA, 22030, United States.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>School of Systems Biology, George Mason University, Fairfax, VA, 22030</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">The FEBS journal</title>
<idno type="eISSN">1742-4658</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The recent emergence of COVID-19 has resulted in a worldwide crisis, with large populations locked down and transportation links severed. While approximately 80% of infected individuals have minimal symptoms, around 15-20% need to be hospitalized, greatly stressing global health care systems. As of March 10, the death rate appears to be about 3.4%, although this number is highly stratified among different populations. Here, we focus on those individuals who have been exposed to nicotine prior to their exposure to the virus. We predict that these individuals are "primed" to be at higher risk because nicotine can directly impact the putative receptor for the virus (ACE2) and lead to deleterious signaling in lung epithelial cells.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32189428</PMID>
<DateRevised><Year>2020</Year>
<Month>03</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1742-4658</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year>
<Month>Mar</Month>
<Day>18</Day>
</PubDate>
</JournalIssue>
<Title>The FEBS journal</Title>
<ISOAbbreviation>FEBS J.</ISOAbbreviation>
</Journal>
<ArticleTitle>Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population?</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/febs.15303</ELocationID>
<Abstract><AbstractText>The recent emergence of COVID-19 has resulted in a worldwide crisis, with large populations locked down and transportation links severed. While approximately 80% of infected individuals have minimal symptoms, around 15-20% need to be hospitalized, greatly stressing global health care systems. As of March 10, the death rate appears to be about 3.4%, although this number is highly stratified among different populations. Here, we focus on those individuals who have been exposed to nicotine prior to their exposure to the virus. We predict that these individuals are "primed" to be at higher risk because nicotine can directly impact the putative receptor for the virus (ACE2) and lead to deleterious signaling in lung epithelial cells.</AbstractText>
<CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Olds</LastName>
<ForeName>J L</ForeName>
<Initials>JL</Initials>
<AffiliationInfo><Affiliation>SCHAR School of Public Policy, George Mason University, Arlington, VA, 22201, United States.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kabbani</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>School of Systems Biology, George Mason University, Fairfax, VA, 22030, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>03</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>FEBS J</MedlineTA>
<NlmUniqueID>101229646</NlmUniqueID>
<ISSNLinking>1742-464X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>03</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>03</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>3</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>3</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>3</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32189428</ArticleId>
<ArticleId IdType="doi">10.1111/febs.15303</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000315 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000315 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= CovidV2 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:32189428 |texte= Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:32189428" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a CovidV2
This area was generated with Dilib version V0.6.33. |